Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Concussion
Danaher launches collaboration with Johns Hopkins University on TBI diagnostics
Danaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.
Featured
PCR
Qiagen partners with FBI on forensics assay
Proteomics
Biodesix reports doubling lung nodule testing activity
Latest News
University of Florida researchers develop CRISPR-based assay for HPV detection
May 7, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
German court rules patent invalid in 10x infringement suit against NanoString
May 8, 2024
FDA said no to proficiency testing for LDT quality
May 2, 2024
Business Insights
PCR
Qiagen partners with FBI on forensics assay
Proteomics
Biodesix reports doubling lung nodule testing activity
Mergers & Acquisitions
Myriad Genetics reorganizes EU operations, sells EndoPredict business
FDA Clearance
Geneoscopy receives FDA approval for CRC screening test
Diagnostic Technologies
PCR
Qiagen partners with FBI on forensics assay
Immunoassays
University of Florida researchers develop CRISPR-based assay for HPV detection
Financing
Karius raises $100M in series C funding
Diagnostic Technologies
FDA said no to proficiency testing for LDT quality
Diseases
Concussion
Danaher launches collaboration with Johns Hopkins University on TBI diagnostics
Immunoassays
University of Florida researchers develop CRISPR-based assay for HPV detection
FDA Clearance
Geneoscopy receives FDA approval for CRC screening test
Collaboration
Astellas and Poseida to collaborate on oncology cell therapies
More from LabPulse.com
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024
Vertex to pay $25M upfront to scale cell manufacturing technology
By
LabPulse.com staff writers
As part of the deal, Vertex was also willing to pay up to $215 million in milestones achieved in connection with the development of a scaled-up process for fully differentiated islet cells.
April 25, 2024
Labcorp buys Invitae portfolio for $239M
By
LabPulse.com staff writers
Labcorp was the winning bidder in the court-supervised auction of Invitae's assets, obtaining substantially all of the San Francisco-based company's business for $239 million in cash consideration with other noncash consideration.
April 26, 2024
Bristol Myers Squibb to reduce workforce in restructuring plan
By
LabPulse.com staff writers
As part of a restructuring plan intended to cut $1.5 billion in costs, Bristol Myers Squibb plans to cut about 6% of its workforce, according to the firm.
April 25, 2024
U.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuit
By
LabPulse.com staff writers
The Patents Court of the High Court of England and Wales has ruled that two patents owned by Bio-Techne are invalid, rejecting a patent infringement lawsuit filed by Bio-Techne/ACD in the U.K. against Molecular Instruments.
April 24, 2024
Scout secures CARB-X grant to advance diagnostic test development
By
LabPulse.com staff writers
Scout, formerly Uh Oh Labs, will advance its point-of-care (POC) diagnostic test for sexually transmitted infections (STIs) with a new $1 million accelerator grant.
April 22, 2024
Mission Bio launches new features for Tapestri platform
By
Matt Limb
Mission Bio has launched new multiplexing features for its Tapestri platform, saying they will make single-cell technology more affordable and accessible to the biomedical community.
April 24, 2024
Quest adds new biomarker test to Alzheimer's portfolio
By
LabPulse.com staff writers
Quest Diagnostics has launched a new blood biomarker test as part of its AD-Detect portfolio of blood tests for Alzheimer's disease risk assessment.
April 23, 2024
Bio-Techne files EU patent infringement suit against Molecular Instruments
By
LabPulse.com staff writers
Life sciences company Bio-Techne has filed a lawsuit against Molecular Instruments in the pan-European Unified Patent Court, alleging patent infringement of its RNAscope in situ hybridization technology.
April 23, 2024
Target ALS launches new data portal for research
By
Matt Limb
A nonprofit medical research foundation has launched a data portal designed to help spur scientific breakthroughs for the disease amyotrophic lateral sclerosis (ALS).
April 23, 2024
Ipsen, Skyhawk to collaborate on drug discovery for rare neurological disorders
By
LabPulse.com staff writers
Biopharmaceutical company Ipsen and clinical-stage biopharmaceutical firm Skyhawk have signed an exclusive collaboration to discover and develop small-molecule therapeutics targeting RNA to treat rare neurological disorders.
April 22, 2024
Engineered Cas clears barrier to antiviral CRISPR therapies
By
Nick Paul Taylor
Researchers have engineered a Cas enzyme to enhance activity against RNA viruses, resulting in a system that completely blocked the replication of various SARS-CoV-2 strains.
April 19, 2024